8-K: Owens & Minor Divests P&HS Segment for $375M Cash, Retains Equity

Owens & Minor announced a definitive agreement to sell its Products & Healthcare Services segment to Platinum Equity for $375 million in cash, plus a 5% retained equity stake and over $150 million in tax attributes, as it shifts focus to home-based care.

Summary

• Owens & Minor, Inc. (OMI) entered into a definitive agreement to sell its Products & Healthcare Services (P&HS) segment to Dominion Healthcare Acquisition Corporation, an affiliate of Platinum Equity.
• The transaction includes a cash payment of $375 million to Owens & Minor at closing, subject to customary adjustments for cash, indebtedness, net working capital, and transaction expenses.
• Owens & Minor will retain a 5% equity interest in the P&HS business (Rollover Company Securities) and receive Rollover Units in Purchaser Parent.
• The Rollover Units entitle Owens & Minor to 50% of distributions after Purchaser Parent makes aggregate distributions of $310 million, until Owens & Minor receives $200 million, and 5% of distributions exceeding these priority returns.
• Owens & Minor will also retain over $150 million in specified tax assets, including federal net operating loss carryforwards and other tax attributes.
• The transaction is expected to close near the end of the year, subject to customary closing conditions, including Hart-Scott-Rodino Act and other regulatory approvals.
• Owens & Minor will reimburse Purchaser for 80% of certain separation costs, capped at $65 million, with specific payment thresholds: no payments before April 1, 2026; maximum $15 million before October 1, 2026; and maximum $55 million before January 1, 2027.
• Owens & Minor may be obligated to provide up to $115 million in credit support to the P&HS business under the transition services agreement.

Sentiment

Score: 8

Explanation: The sentiment is positive as Owens & Minor is executing a clear strategic transformation, divesting a segment for a substantial cash payment while retaining an equity upside and significant tax assets. This clear strategic direction and enhanced financial flexibility are expected to drive long-term value.

Positives

• Receives $375 million in cash, providing liquidity for strategic reallocation or debt reduction.
• Retains a 5% equity stake and preferred equity return, offering potential for future value creation if the divested business performs well under Platinum Equity.
• Retains over $150 million in valuable tax assets, including federal net operating loss carryforwards and other tax attributes.
• Allows Owens & Minor to transform into a 'pure play' market leader in the home-based care market, simplifying its business model and enabling a more appropriate valuation.
• Enables dedication of resources to the more profitable part of the legacy business, expected to drive consistent revenue and profit growth.
• Platinum Equity's commitment to investing in and growing the P&HS business as a standalone company provides a clear path for the divested segment.

Negatives

• Owens & Minor is obligated to reimburse Purchaser for 80% of certain separation costs, capped at $65 million, representing a significant future cash outflow.
• Potential obligation to provide up to $115 million in credit support to the divested P&HS business under the transition services agreement.
• The non-compete clause restricts Owens & Minor from engaging in competitive business for 5 years, potentially limiting future growth avenues in related sectors.
• Risk of not realizing the full potential value from the 5% retained equity stake if the divested business does not perform as expected.
• Termination fees are relatively small compared to the transaction value ($9.375 million or $18.75 million), potentially not fully compensating for a failed transaction.

Risks

• Failure to satisfy customary closing conditions, including Hart-Scott-Rodino Act and other regulatory approvals.
• Governmental entity prohibiting, delaying, or refusing to grant approval for the consummation of the transactions.
• Disruption of management's attention from ongoing business operations dues to the proposed transactions.
• The effect of the announcement on relationships with customers, suppliers, and other third parties, as well as operating results and business generally.
• Risk that the proposed transactions will not be consummated in a timely manner.
• Exceeding the expected costs of the transactions.
• Risk that the Purchaser will fail to consummate the transactions when required.
• Risks related to the Purchaser's committed financing.
• Risk that the remaining business will not operate as effectively and efficiently as expected.
• Potential for the Saudi Arabian JV sale to not materialize or yield expected proceeds, or requiring transfer for a nominal $1.
• Potential for the divested P&HS business to not perform well, impacting the value of the retained 5% equity stake.

Future Outlook

Owens & Minor expects to transform into a pure-play home-based care platform, driving consistent revenue and profit growth by dedicating resources to this more profitable segment. The divested Products & Healthcare Services business is anticipated to grow and undergo operational transformation under Platinum Equity's ownership.

Management Comments

• "Today's announcement represents another critical step forward in the strategic transformation of Owens & Minor into a leading, pure play home based care platform." Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
• "With the definitive agreement in place for Products & Healthcare Services, we will remain laser-focused on transforming the Company into a pure-play home-based care business that will drive even more value for our Patient Direct stakeholders." Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
• "Going forward, we will be positioned among the leaders in a dynamic market where we will be able to capitalize on our leading brands and long-standing record of putting the patient first while delivering consistent revenue and profit growth." Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
• "The ability to dedicate our resources to the more profitable part of the legacy business will be value-enhancing for many years to come." Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
• "Platinum Equity is the perfect home for the Products & Healthcare Services business and their commitment to building on the customer-centric legacy of the business and to strategically invest to stay at the forefront of the evolving healthcare market will serve all stakeholders very well long into the future." Edward A. Pesicka, President & Chief Executive Officer, Owens & Minor.
• "Owens & Minor has played a vital role in supporting healthcare providers and patients across the country, and we are proud to invest in the future of P&HS." Jacob Kotzubei, Co-President, Platinum Equity.
• "We are pleased to provide Owens & Minor a divestiture solution for P&HS and are grateful for the continued partnership." Jacob Kotzubei, Co-President, Platinum Equity.
• "With the support of Platinum's operational resources, we are committed to further enhancing P&HS's global capabilities to deliver essential products and services when and where its customers need." Jacob Kotzubei, Co-President, Platinum Equity.
• "We are committed to growing the P&HS business and have strong conviction in its potential as a standalone company." Matthew Louie, Managing Director, Platinum Equity.
• "We look forward to working with the team to support its continued growth and operational transformation." Matthew Louie, Managing Director, Platinum Equity.

Industry Context

This divestiture positions Owens & Minor to become a pure-play leader in the rapidly expanding home-based care market, aligning with broader healthcare trends emphasizing care outside traditional hospital settings. This strategic focus allows the company to capitalize on its existing brands and expertise in a dynamic and profitable segment, while the divested P&HS segment gains a new owner, Platinum Equity, with a track record in healthcare and supply chain investments, suggesting a focus on operational enhancements and growth as a standalone entity.

Stakeholder Impact

• Shareholders (Owens & Minor): Expected to benefit from a simplified business model, focus on profitable home-based care, cash inflow, retained equity upside, and significant tax attributes.
• Employees (P&HS segment): Employment with the divested entity will continue under Platinum Equity, with certain terms and conditions of employment, service credit, and benefits maintained until at least December 31, 2026.
• Customers (P&HS segment): Platinum Equity is committed to building on the customer-centric legacy and enhancing global capabilities to deliver essential products and services.
• Suppliers (P&HS segment): Platinum Equity is committed to enhancing global capabilities, which may impact supplier relationships and volumes.
• Creditors (Owens & Minor): Cash inflow from the sale could be used to strengthen the balance sheet or reduce debt.
• Creditors (P&HS segment): New ownership by Platinum Equity and its financing arrangements will impact the credit profile of the standalone P&HS business.

Next Steps

• Completion of customary closing conditions, including Hart-Scott-Rodino Act and other regulatory approvals.
• Closing of the sale transaction, expected near the end of the year.
• Owens & Minor to release Q3 2025 financial results on October 31, 2025.
• Purchaser and Seller to coordinate on communications strategy for Business Employees.
• Seller to complete pre-closing restructuring and separation activities.
• Purchaser to establish a defined contribution plan (Purchaser DC Plan) for Transferred Business Employees.
• Seller to cause transfer of 401(k) accounts to Purchaser DC Plan.
• Purchaser to adopt standalone health and welfare benefit plans (Replacement Benefit Plans) for US Transferred Business Employees by January 1, 2026.
• Seller to use reasonable best efforts to process and support visa, work permit, green card, or similar applications for Business Employees.
• Seller and Purchaser to cooperate on amending certain logistics and supply agreements (Byram Amendments).
• Potential sale or transfer of Saudi Arabian JV interest by Seller.
• Potential transfer of Tally Surgical to Purchaser's affiliate.

Key Dates

Recommendation

The divestiture of the Products & Healthcare Services segment for $375 million in cash, coupled with a retained 5% equity stake and over $150 million in tax attributes, is a strategically sound move for Owens & Minor. This transaction allows the company to streamline its operations and focus entirely on the high-growth, more profitable home-based care market. The retained equity provides an upside potential from the divested business's future performance under Platinum Equity, while the cash infusion and tax assets strengthen Owens & Minor's financial position. This clear strategic direction and enhanced financial flexibility make the stock an attractive 'buy' for long-term investors.

Keywords

Owens & Minor, OMI, Platinum Equity, Divestiture, Healthcare Services, Products, Home-Based Care, SEC Filing, 8-K, Mergers & Acquisitions, Financial Reporting, Tax Assets, Equity Stake, Corporate Strategy